ITORIHENZ 50

About

ITORIHENZ 50 is a non-steroidal anti-inflammatory drug (NSAID) specifically classified as a selective cyclooxygenase-2 (COX-2) inhibitor. Its primary mechanism of action involves selectively blocking the COX-2 enzyme, which plays a crucial role in the biosynthesis of prostaglandins. These prostaglandins are key mediators of pain, inflammation, and fever within the body. By inhibiting COX-2, ITORIHENZ 50 effectively mitigates the inflammatory cascade and alleviates associated symptoms, while largely sparing the COX-1 enzyme. COX-1 is vital for maintaining the integrity of the gastrointestinal lining and supporting normal platelet function. This selective inhibition aims to provide potent analgesic and anti-inflammatory effects with a potentially reduced risk of gastrointestinal adverse events, such as ulcers or bleeding, compared to conventional non-selective NSAIDs. It is commonly indicated for the symptomatic treatment of various chronic inflammatory and painful conditions, offering targeted relief.

Uses

• Relief of pain and inflammation in osteoarthritis.
• Management of symptoms in rheumatoid arthritis.
• Treatment of ankylosing spondylitis.
• Alleviation of acute gouty arthritis pain.

Directions For Use

Take orally with or without food, as directed by your physician. Do not exceed the prescribed dose.

Benefits

• Effective pain relief.
• Reduces inflammation and swelling.
• Improves joint mobility.
• Long-lasting action.
• Potentially lower GI side effects than traditional NSAIDs.
• Convenient once-daily dosing for some indications.

Side Effects

• Abdominal pain
• Nausea
• Diarrhea
• Indigestion
• Headache
• Dizziness
• Fluid retention
• High blood pressure
• Palpitations
• Fatigue
• Swelling of ankles/legs
• Heartburn

Safety Measures

• Alcohol - Concurrent use of alcohol with ITORIHENZ 50 may increase the risk of gastrointestinal irritation and bleeding. It is advisable to limit or avoid alcohol consumption.
• Pregnancy - ITORIHENZ 50 is generally not recommended during pregnancy, especially in the third trimester, due to potential risks to the fetus, including premature closure of the ductus arteriosus. Consult a doctor.
• Breastfeeding - Small amounts of NSAIDs may pass into breast milk. Use during breastfeeding should be approached with caution and only if clearly necessary, under medical supervision.
• Liver - Use with caution in patients with mild to moderate liver impairment. ITORIHENZ 50 is contraindicated in severe liver disease due to increased risk of adverse effects.
• Kidney - Caution is advised in patients with pre-existing kidney disease as NSAIDs can impair renal function. Regular monitoring of kidney function may be necessary.
• Lung - Patients with asthma, especially aspirin-sensitive asthma, should use ITORIHENZ 50 with caution as it may exacerbate bronchospasm.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.